Novel 9-(alkylthio)-Acenaphtho[1,2-e]-1,2,4-triazine derivatives: synthesis, cytotoxic activity and molecular docking studies on B-cell lymphoma 2 (Bcl-2)

Abstract

Background and purpose of the studyAcenaphtho derivatives have been reported as antitumor agents. Due to this fact and also with the aim of developing the chemistry of potentially bioactive heterocyclic compounds via efficient reactions, a facile procedure for the synthesis of 9-(alkylthio)-acenaphtho[1,2-e]-1,2,4-triazines via two step condensation of thiosemicarbazide and acenaphtylene-9,10-quinone to form acenaphtho[1,2-e]-1,2,4-triazine-9(8H)-thiones and subsequent reaction with benzyl chloride derivatives is reported.Methods9-(alkylthio) acenaphtho[1,2-e]-1,2,4-triazines were synthesized via the reaction of acenaphtho-9,10-quinone with thiosemicarbazide, and then with the benzyl chloride derivatives. Cytotoxicity of some prepared compounds was assessed through MTT assay on three different human cancerous cell lines (HL-60, MCF7, and MOLT-4 cells). Molecular docking studies were performed via AutoDock4.2 software in order to confirm an apoptosis-inducing activity of acenaphtho scaffolds via the Bcl-2 protein.ResultsExcellent yields of the products, short reaction times and simple work-up are attractive features of this synthetic protocol. The evaluated compounds exhibited moderate to good cytotoxic activities. Docking results on the active site of B-cell lymphoma 2 (Bcl-2) supported the experimental biological data and agreed well with previous in silico data for commonly used anti-cancer drugs. Moreover; results were analyzed considering binding efficiency indices.ConclusionsThe outcomes of the present study may be helpful in future targeting of Bcl-2 with the aim of developing apoptosis-inducing agents.

Complex disruption effect of natural polyphenols on Bcl-2-Bax: molecular dynamics simulation and essential dynamics study

“…All the previous studies regarding the inhibition of Bcl-2 were mainly targeted to the Bax-unbound form of Bcl-2 (Acoca et al, 2011;Mohammadi et al, 2014;Saxena et al, 2013) in our knowledge. It is well defined that the interaction of bcl-2 and bax is mainly dependent on few residues of both proteins.…”

Synthesis, Biological Evaluation and Molecular Docking of Novel Curcumin Derivatives as Bcl‐2 Inhibitors Targeting Human Breast Cancer MCF‐7 Cells

“…All the twenty four compounds showed scores with Bcl‐2 ranging from 4970 to 6028 with Patch Dock, as presented in Table . The complex structure with highest docking score was highly probable and energetically favorable and it was selected for further analysis . All compounds established a network of molecular interactions (conventional H‐bonds, C−H bonds, Pi−Pi T shaped, Van der Waals, alkyl, Pi‐alkyl, Pi‐Lone pair, Pi‐cation, Pi‐anion and halogen bonds) with the human Bcl‐2 isoform II (PDB ID:1GJH) when analyzed in 2D plots.…”

Prediction of Protein-Ligand Binding Sites for Cisplatin and Transplatin based on Hydrogen Bonds

“…For BCL-2 protein the analysis were more complicated, because the structure of this protein was defined by NMR technique that provides several models, and only the first model was analysed. According to article [39] there are some potential binding sites for cisplatin such as Glu 13. Indeed, in our method Glu 13 was ranked in second place.…”

“…Ubiquitin has two binding-sites in which the residue for the first binding-site is Met 1 and the second is His 68 [38]. Finally, the protein BCL-2 (PDB ID: 1G5M) was chosen because its structure was determined by NMR technique and there was a precise description about the residue that binds to platinum, which is Glu 13 [39]. In this work, all selected proteins have no covalently bound HETATM but only coordinated groups such as cofactors (Cu, Zn or Heme group) or water.…”